These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10349670)

  • 21. Are oestrogens useful for the treatment of depression in women?
    Studd J; Panay N
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):63-71. PubMed ID: 19110473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hormone replacement therapy with a transdermal estradiol gel and oral micronized progesterone. Effect on menopausal symptoms and lipid metabolism].
    Giuliani A; Concin H; Wieser F; Boritsch J; Wilfert H; Gruber D; Urdl W
    Wien Klin Wochenschr; 2000 Jul; 112(14):629-33. PubMed ID: 11008325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using progestins in clinical practice.
    Apgar BS; Greenberg G
    Am Fam Physician; 2000 Oct; 62(8):1839-46, 1849-50. PubMed ID: 11057840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HEDIS 2000 measures zero in on women's health issues.
    Healthc Demand Dis Manag; 1999 Jul; 5(7):101-4. PubMed ID: 10621119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progesterone: review of safety for clinical studies.
    Goletiani NV; Keith DR; Gorsky SJ
    Exp Clin Psychopharmacol; 2007 Oct; 15(5):427-44. PubMed ID: 17924777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promoting wellness in women across the life span.
    Zender R; Olshansky E
    Nurs Clin North Am; 2009 Sep; 44(3):281-91. PubMed ID: 19683090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A qualitative investigation of women's perceptions of premenstrual syndrome: implications for general practitioners.
    Reilly J; Kremer J
    Br J Gen Pract; 1999 Oct; 49(447):783-6. PubMed ID: 10885080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.
    Mattsson LA; Skouby S; Rees M; Heikkinen J; Kudela M; Stadnicki-Kolendo A; Mattila L; Salminen K; Vuorela A; Mustonen M;
    Menopause Int; 2007 Sep; 13(3):124-31. PubMed ID: 17785038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endometrial response to a cyclic regimen of percutaneous 17beta-estradiol and low-dose vaginal micronized progesterone in women with mild-to-moderate hypertension.
    Vilodre LC; Osório Wender MC; Sisson de Castro JA; dos Reis FM; Ruschel S; Magalhães JA; Spritzer PM
    Gynecol Endocrinol; 2003 Aug; 17(4):323-8. PubMed ID: 14503977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epilepsy and women's health issues: unmet needs--survey results from women with epilepsy.
    Vazquez B; Gibson P; Kustra R
    Epilepsy Behav; 2007 Feb; 10(1):163-9. PubMed ID: 17088109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Menopausal issues: a national probability sample of US women.
    Singh B; Liu XD; Der-Martirosian C; Hardy M; Singh VJ; Shepard N; Khorsan R
    Altern Ther Health Med; 2007; 13(3):24-9. PubMed ID: 17515021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A new association of megestrol acetate and ethinyl estradiol in gynecologic therapy. Preliminary results].
    Signorelli I; Emanueli A
    Minerva Ginecol; 1969 Apr; 21(8):512-22. PubMed ID: 5815438
    [No Abstract]   [Full Text] [Related]  

  • 33. Micronized progesterone: clinical indications and comparison with current treatments.
    Fitzpatrick LA; Good A
    Fertil Steril; 1999 Sep; 72(3):389-97. PubMed ID: 10519605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic experiences with Praemenstron in the premenstrual syndrome].
    Beltermann R
    Z Allgemeinmed; 1974 Mar; 50(7):306-1. PubMed ID: 4859173
    [No Abstract]   [Full Text] [Related]  

  • 35. Progesterone.
    Harv Womens Health Watch; 1999 Jul; 6(11):2-3. PubMed ID: 10368546
    [No Abstract]   [Full Text] [Related]  

  • 36. Sleep and menopause.
    Landis CA; Moe KE
    Nurs Clin North Am; 2004 Mar; 39(1):97-115. PubMed ID: 15062730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Added benefits of drospirenone for compliance.
    Foidart JM
    Climacteric; 2005 Oct; 8 Suppl 3():28-34. PubMed ID: 16203653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral micronized progesterone. Bioavailability pharmacokinetics, pharmacological and therapeutic implications--a review.
    Sitruk-Ware R; Bricaire C; De Lignieres B; Yaneva H; Mauvais-Jarvis P
    Contraception; 1987 Oct; 36(4):373-402. PubMed ID: 3327648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combined treatment of premenstrual tension syndrome with dehydrating and hormonal agents].
    Potocki J; Guzel L; Szymborski A
    Wiad Lek; 1969 Nov; 22(22):2047-50. PubMed ID: 5392145
    [No Abstract]   [Full Text] [Related]  

  • 40. The dilemma of menopause and hormone replacement--a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women.
    Castelo-Branco C; Peralta S; Ferrer J; Palacios S; Cornago S; Quereda F
    Climacteric; 2006 Oct; 9(5):380-7. PubMed ID: 17000585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.